Methuselah Foundation Launches NewOrgan Prize

Multi-Million Dollar Award Will Recognize Advances in Regenerative Medicine --
Specifically, the Creation of Replacement Tissues and Organs That Extend Healthy
Human Life
WASHINGTON--(Business Wire)--
Today Methuselah Foundation launched the NewOrgan Prize, the Foundation`s new
longevity prize specifically focused on advancing the development of replacement
tissues and organs for humans. Its goal is to accelerate advances in
regenerative medicine, which will become the standard of care for replacing all
tissue and organ systems in the body within 20 years, according to the U.S.
Department of Health and Human Services.*

The first research team to construct a whole new complex organ (heart, kidney,
liver, lung, pancreas) made from a person`s own cells -one that is functionally
equivalent and successfully transplanted- will be awarded the NewOrgan Prize.
The goal of the Methuselah Foundation NewOrgan Prize is to achieve this medical
breakthrough within the next 10 years. Today`s launch is a call to action for
competitors, candidates and contributors who want to participate in this crucial
medical challenge aimed at extending healthy human life.

"Based on our success in spurring medical advances with incentives provided by
the original Methuselah Mouse prize, we anticipate that over $10 million will be
raised by the time the NewOrgan Prize criteria is met -and the prize presented-
to the leading medical R&D team," noted Methuselah Foundation CEO David Gobel.
"At minimum, $1 million will be awarded to the research team that develops a
whole new human organ that is functional and successfully transplanted."
Potential competitors can reach Methuselah Foundation at info@mfoundation.org.

To date, Methuselah Foundation has secured commitments for $3.8 million for
prizes to be awarded for specific medical advances. To help support those in
need of replacement organs, Methuselah Foundation is also establishing the
NewOrgan Network, a wellness community powered by My Bridge 4 Life. At the
NewOrgan Network, those in need of replacement organs can reach out to friends
and family for personal support --- and help drive scientific progress via the
NewOrgan Prize. Prospective members of the community can learn more and join the
NewOrgan Network at http://www.neworgannetwork.com.

Since 2003, three Methuselah Foundation Mprizes have been presented to
researchers, including the Mprize given to Dr. David Sharp for the first drug
proven to extend healthy maximum lifespan in mice. All of these prizes recognize
breakthroughs that extend the lifespan of mice; they`re often referred to as the
`Methuselah Mouse` prizes. In addition to the Mprize series, Methuselah
Foundation also funds innovative new companies that are creating breakthrough
technologies, products, and solutions. One example is Organovo
, which has created the world`s first commercial 3D
Bio-Printer for manufacturing human tissue and organs. The Foundation believes
that this kind of enabling technology will be key to achieving the goals of the
NewOrgan Prize.

Methuselah Foundation introduced the first Mprize in 2003 to accelerate the
development of revolutionary new life extension innovations. Inspired by the
18th century Longitude Prize, the Mprizes are a series of cash incentive prizes
given to the first teams of doctors or scientists to achieve specific
life-extending medical goals. Studies have shown that an incentive prize can
generate activity worth 50 times its value; that is, a $10 million incentive
prize can spark $500 million in scientific research and development.
.

The Obama Administration recently introduced a Strategy for American Innovation,
calling for agencies to increase their ability to promote and harness innovation
by using policy tools such as prizes and challenges. See:
http://www.whitehouse.gov/omb/assets/memoranda_2010/m10-11.pdf

Methuselah Foundation`s scientific advisory board includes several luminaries in
the biological research and regenerative medicine field: Anthony Atala, MD, W.H.
Boyce Professor, Director of the Institute for Regenerative Medicine, and chair
of the Department of Urology at Wake Forest University; Stephen F. Badylak,
Professor, Department of Surgery and Deputy Director, the McGowan Institute for
Regenerative Medicine at the University of Pittsburgh; Robert Cohen, CEO,
Miromatrix; Gabor Forgacs, biological physicist at the University of
Missouri-Columbia; Keith Murphy, CEO and President, Organovo; and Doris Taylor,
Ph.D, Director, Center for Cardiovascular Repair Medtronic Bakken, Professor of
Integrative Biology and Physiology, Professor of Medicine at the University of
Minnesota.

Methuselah Foundation is a non-profit medical charity dedicated to extending
healthy human life. Supported by the donations of individuals and organizations,
the programs of Methuselah Foundation include near, mid and long term strategies
that advance the mission of ending age-related disease through awareness,
education, scientific research and direct community outreach. For more
information please visit: www.methuselahfoundation.org.

*http://www.hhs.gov/reference/newfuture.shtml

Editors, please note: Broadcast quality video footage with additional
information about the Methuselah Foundation and the NewOrgan Prize can be
downloaded at: https://download.yousendit.com/RmNCOU1ha0RoeVpjR0E9PQ

or viewed on YouTube: http://www.youtube.com/watch?v=cvxiANklVIc

Methuselah Foundation
Susan DeVico, 510-339-1527 (media only)
SusanDV@aol.com

Copyright Business Wire 2010